The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adebrelimab in combination with anlotinib and chemotherapy as neoadjuvant therapy for resectable stage II-III non–small cell lung cancer (NSCLC): A prospective, single-arm, phase II trial.
 
Meng Wang
No Relationships to Disclose
 
Yu Zhang
No Relationships to Disclose
 
Bin Jia
No Relationships to Disclose
 
Changli Wang
No Relationships to Disclose
 
Jie Xu
No Relationships to Disclose
 
Shengguang Wang
No Relationships to Disclose
 
Xiaoliang Zhao
No Relationships to Disclose
 
Yue Li
No Relationships to Disclose
 
Chengmeng Wang
No Relationships to Disclose
 
Hua Zhang
No Relationships to Disclose
 
Xiaofei Wang
No Relationships to Disclose
 
Shuai Yuan
No Relationships to Disclose